Pallas Capital Advisors LLC Invests $3.83 Million in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Pallas Capital Advisors LLC bought a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the fourth quarter, HoldingsChannel.com reports. The fund bought 58,258 shares of the company’s stock, valued at approximately $3,829,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. FMR LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 10.9% during the 3rd quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after purchasing an additional 1,338 shares during the last quarter. Jane Street Group LLC raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 5.5% in the third quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after acquiring an additional 616 shares during the last quarter. Marshall Wace LLP acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth approximately $422,000. Mercer Global Advisors Inc. ADV grew its position in iShares U.S. Pharmaceuticals ETF by 7.4% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock worth $254,000 after acquiring an additional 266 shares during the last quarter. Finally, Sequoia Financial Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $204,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

iShares U.S. Pharmaceuticals ETF stock traded up $1.39 on Monday, reaching $67.27. The company’s stock had a trading volume of 104,136 shares, compared to its average volume of 75,262. The business’s fifty day moving average price is $67.47 and its 200 day moving average price is $68.99. The company has a market cap of $679.43 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a twelve month low of $62.31 and a twelve month high of $72.94.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.